FDA advisory panel voted to allow compounding pharmacies to make 6 of 7 peptides, despite safety/efficacy concerns, with Revelation Pharma's Shawn Hodges cautiously optimistic.
July 28, 2026 10:24 AM EDT
Health Tech
The future of gray-market peptides
Shelby Livingston
Health tech correspondent
FDA Panel Backs Wider Access To Six Peptide Therapies, Citing Grey Market Concerns
Is a peptide boom underway? FDA advisers vote for looser rules
FDA Panel Clears the Way for 6 Banned Peptides. Here's What They're Claimed to Do
UPDATE: Peptides favored on 1st day of closely watched FDA compounding adcomm
FDA panel reviewing some peptides to consider loosening regulations for unapproved therapies
Pharmalittle: We're reading about an FDA panel and peptides, a Merck license for an HIV pill, and more
FDA advisers support easing restrictions on six peptides. Here’s what those drugs are and what happens next | CNN
On Peptides, FDA Staff Scientists At Odds With Advisory Panel
An FDA Committee Just Voted in Favor of Peptides—Despite the Agency's Opposition
US panel backs trendy peptides despite safety concerns
FDA advisers are set to consider whether allowing compounding pharmacies to offer largely unproven peptides is a safer bet than…
An FDA committee will meet next month to discuss lifting a ban on a number of peptides marketed for wellness. Compounding…
An FDA panel is reviewing seven peptides for potential approval, sparking concerns about their widespread use in compounding…
A FDA advisory committee will review evidence surrounding peptides. Experts are concerned there is a paucity of evidence to back…
U.S. FDA advisers this week will weigh whether seven popular peptides can be compounded by licensed pharmacies, but even if…
Peptides are short chains of amino acids that help regulate metabolism, growth and tissue repair...
